Iyengar Capital Partners
Iyengar Capital Partners is a private venture capital firm investing in clinical development stage medical device companies, leveraging physician-partner clinical expertise to back women's health, neurodiagnostic, and surgical device companies positioned for value-oriented healthcare systems.
- Company typePrivate
- Founded2022
- HeadquartersMissouri City, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Iyengar Capital Partners does
Iyengar Capital Partners is a private venture capital investment firm specializing in clinical development stage medical device companies. Founded in 2022 and headquartered in Clayton, Missouri, the firm operates with a small team (1–10 employees) and invests at the stage of medical device development where clinical evidence is being generated but regulatory approval and commercial scaling remain ahead — a risk-return band positioned between traditional venture capital and later-stage PE or growth equity.
The firm's core differentiator is the clinical and healthcare expertise of its partners, who are themselves physicians and have completed the clinical-stage medical device investment journey multiple times. The stated investment thesis targets companies building products designed to perform in a value-oriented healthcare system, with disclosed portfolio exposure spanning women's health devices (Rejoni's Juveena Hydrogel System), neurological diagnostics (Sora Neuroscience's fMRI software), surgical nerve treatments for amputees and trauma patients (Tulavi, in partnership with VHSS for veterans), and neurovascular recovery (Kandu). Portfolio company milestones visible in 2025–2026 include a $25M Rejoni financing round, an FDA 510(k) clearance for Sora Neuroscience, a CEO appointment at Rejoni, and leadership expansion at Kandu.
Iyengar's business model is that of an emerging clinical-stage medical device venture manager: capital is deployed from a fund into portfolio companies, with returns generated through management fees during the fund's life and carried interest on successful exits. No fund size, AUM, LP base, or fee schedule is publicly disclosed. The firm does not sell products or services to end customers, does not employ traditional marketing or distribution channels, and reaches founders primarily through professional networks, industry relationships, and direct outreach anchored in the partners' physician credentials.
Iyengar Capital Partners firmographics
Firmographics- Name
- Iyengar Capital Partners
- Legal name
- Iyengar Capital
- Website
- https://iyengarcap.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Iyengar Capital Partners is a private venture capital firm investing in clinical development stage medical device companies, leveraging physician-partner clinical expertise to back women's health, neurodiagnostic, and surgical device companies positioned for value-oriented healthcare systems.
- Ownership category
- akta.pro rank
Iyengar Capital Partners industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Iyengar Capital Partners is headquartered
LocationHeadquarters
- HQ city
- Missouri City
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Iyengar Capital Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
Iyengar Capital Partners product offering
Product offeringCore offering
Iyengar Capital Partners is a healthcare and life sciences venture capital firm that invests in innovative medical device companies at the clinical development stage. The firm provides capital and strategic guidance to device companies building products for value-oriented healthcare systems, with a focus on areas including women's health devices, surgical treatments, and neurological diagnostic tools.
Product overview
Iyengar Capital Partners is a private investment firm specializing in clinical development stage medical device companies. The firm provides capital investment and strategic guidance to innovative device companies positioned for value-oriented healthcare systems. Their investment focus is on companies with products designed to address unmet clinical needs, including women's health devices, surgical treatments, and neurological diagnostic tools.
Differentiator
Problem solved
Functional benefit
Companies that use Iyengar Capital Partners
Customer profileIdeal customer profiles1 record
Iyengar Capital Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Iyengar Capital Partners partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights4 records
Iyengar Capital Partners competitors and assessment
Company assessmentBroad incumbents
- New Enterprise Associates (NEA): Large multi-stage venture firm with a sizable healthcare practice covering devices and biopharma. Comparable for healthcare device investing, but operates as a broad incumbent rather than a dedicated specialist.
- KKR Health Care Strategic Growth: Growth equity platform within a large alternative asset manager with significant healthcare and device activity. Comparable as a healthcare-focused investor, but a broad incumbent with multi-sector platform.
Direct peers
- HealthQuest Capital: Sector-focused healthcare growth and late-stage investment firm. Highly comparable to Iyengar in its dedicated medical/healthcare focus, though typically investing at later stages than clinical development.
- Longitude Capital: Healthcare-dedicated venture and growth capital firm investing across medical devices, biopharmaceuticals, and diagnostics. Comparable as a healthcare-specialist with device exposure across stages.
- OrbiMed Advisors: Healthcare-dedicated investment firm across venture, growth, and credit. Comparable as a healthcare-only specialist with deep medical device exposure and physician-scientist networks.
- Frazier Healthcare Partners: Healthcare-focused venture and growth firm investing across therapeutic and medical device companies. Comparable as a sector-specialist with operating expertise and clinical-stage experience.
- SV Health Investors: Healthcare-specialist venture and growth firm with deep device and biotech expertise. Comparable as a healthcare-only manager with clinical-development stage activity.
- Deerfield Management: Healthcare-focused investment firm with venture and credit strategies across medical devices and life sciences. Comparable as a healthcare-specialist with multi-stage and public/private reach.
- ARCH Venture Partners: Early-stage science and medicine venture firm with extensive medical device and biotech investments. Comparable for clinical and translational stage investing with deep scientific networks.
- RA Capital Management: Healthcare-focused investment manager with venture and public equities capabilities. Comparable for healthcare-only thesis and clinical-stage device involvement.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Iyengar Capital Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Iyengar Capital Partners leadership team
Management profileNumber of profiles
Profiles1 record
Iyengar Capital Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Iyengar Capital Partners M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Iyengar Capital Partners
What does Iyengar Capital Partners do?
Iyengar Capital Partners is a healthcare and life sciences venture capital firm that invests in innovative medical device companies at the clinical development stage. The firm provides capital and strategic guidance to device companies building products for value-oriented healthcare systems, with a focus on areas including women's health devices, surgical treatments, and neurological diagnostic tools.
Is Iyengar Capital Partners a public or private company?
Iyengar Capital Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Iyengar Capital Partners founded?
Iyengar Capital Partners was founded in 2022. It employs 1 to 10 people.
Where is Iyengar Capital Partners based?
Iyengar Capital Partners is headquartered in Missouri City, United States, in the North America region.
Who are Iyengar Capital Partners's main competitors?
Broad incumbents on record are New Enterprise Associates (NEA) and KKR Health Care Strategic Growth. Direct peers are HealthQuest Capital, Longitude Capital, OrbiMed Advisors, Frazier Healthcare Partners, SV Health Investors, Deerfield Management, ARCH Venture Partners and RA Capital Management.
Does Iyengar Capital Partners have an API?
No public API is recorded for Iyengar Capital Partners.
What industry is Iyengar Capital Partners in?
Iyengar Capital Partners's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52394 and its SIC code is 6282.